Analyst Thomas McCrann Merrill Lynch said reiterated `` buy '' recommendation Wang Laboratories Inc , noting successful cost cutting campaign could reduce earnings loss expected third quarter ending March .
Wang actively traded stock American Stock Exchange , rising 3/4 16-5/8 .
McCrann said `` Wang little bit ahead expected cost reduction , result , odds increased loss quarter le expected .
'' McCrann said expects Wang report break even earnings per share small loss per share third quarter .
He said year , however , company report loss 50 ct share compared earnings 35 ct share year ago .
Reuter & # 3 ; 